Skip to main content
. Author manuscript; available in PMC: 2008 Dec 1.
Published in final edited form as: Int J Cancer. 2008 Dec 1;123(11):2503–2511. doi: 10.1002/ijc.23828

TABLE IV.

EFFECT OF TJ-48 ON DEVELOPMENT OF MOUSE LIVER TUMORS, AND 8-OHDG- AND PCNA- POSITIVE HEPATOCYTES

Strain Group Weeks Tumor development (%) 8-OHdG-positive hepatocytes (%) PCNA-positive hepatocytes (%)
C57BL/6N Control (N = 5) 10 0 (0/5) 28.7 ± 5.9 36.5 ± 5.6
DEN (N = 5) 0 (0/5) 53.4 ± 1.51 55.6 ± 2.71
DEN + TJ-48 (N = 5) 0 (0/5) 40.2 ± 2.42 55.2 ± 4.41
Control (N = 5) 22 0 (0/5) 26.0 ± 5.7 N/D
DEN (N = 27) 22.23 (6/27) 67.0 ± 2.11 N/D
DEN + TJ-48 (N = 20) 0 (0/20) 24.9 ± 3.52 N/D
C3H/HeN Control (N = 5) 10 0 (0/5) 31.8 ± 1.2 25.3 ± 3.1
DEN (N = 5) 0 (0/5) 59.2 ± 2.31 42.0 ± 3.01
DEN + TJ-48 (N = 5) 0 (0/5) 36.1 ± 3.72 40.9 ± 3.31
Control (N = 5) 22 0 (0/5) 25.8 ± 4.3 N/D
DEN (N = 19) 63.2 (12/19) 37.1 ± 2.6 N/D
DEN + TJ-48 (N = 17) 41.2 (7/17) 26.8 ± 5.0 N/D

Data are expressed as mean ± SEM. N/D, not determined.

1

p < 0.05, compared to control group at the corresponding time point (one-way ANOVA with Newman-Keul’s post-hoc test).

2

p < 0.05, compared to DEN group at the corresponding time point (one-way ANOVA with Newman-Keul’s post-hoc test).

3

p < 0.05, compared to DEN + TJ-48 group at the corresponding time point (Yates 2×2 Chi square test).